NCT05129137View on ClinicalTrials.gov

Pharmacokinetic Study of a Fixed Dose Combination Nefopam Hydrochloride (30 mg) / Paracetamol (500 mg)

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 29, 2021

Primary Completion Date

December 27, 2021

Study Completion Date

December 27, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

nefopam hydrochloride 30mg X2

nefopam hydrochloride 30mg X2

DRUG

paracetamol 500 mg X2

paracetamol 500 mg X2

DRUG

Combination Product: nefopam hydrochloride 30mg / paracetamol 500mg X2

Combination Product: nefopam hydrochloride 30mg / paracetamol 500mg X2

Trial Locations (1)

400709

Accutest Research Laboratories, Navi Mumbai

All Listed Sponsors
collaborator

Accutest Research Laboratories (I) Pvt. Ltd.

INDUSTRY

lead

Unither Pharmaceuticals, France

INDUSTRY

NCT05129137 - Pharmacokinetic Study of a Fixed Dose Combination Nefopam Hydrochloride (30 mg) / Paracetamol (500 mg) | Biotech Hunter | Biotech Hunter